In this installment of the Uromigos Paper of the Month series, Dr. Andrea Apolo talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer.
In this installment of the Uromigos Paper of the Month series, Dr. Andrea Apolo talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer.